Presentations
Upcoming Events
World Vaccine Congress Washington 2025
April 22-24, 2025, Washington, DC
| Date/Time: | April 24, 2025 at 10:25 a.m. EDT (Room 207A) |
| Session Title: | Phase 2b Study Results That Evaluated and Compared GeoVax’s Multi-Antigen, Vaccine Candidate (GEO-CM04S1) to an Approved Vaccine Against COVID-19 |
| Speaker: | Don J. Diamond, PhD, Director, Division of Vaccine Research & Professor, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center |
American Association of Cancer Research
April 25-30, 2025, Chicago, IL
| Date/Time: | April 29, 2025 from 9:00 a.m. to 12:00 p.m. CDT |
| Session Title: | Viral-Vectored, Gene-Directed Prodrug Therapy (Gedeptin) in Needle-Accessible Solid Tumors |
| Speaker: | J. Marc Pipas, MD, Executive Medical Director, Oncology |
Past Events
Emerging Growth Conference
Q4/FY 2024 GeoVax Labs, Inc. Corporate Update
March 27, 2025 - 4:30 PM ET
37th Annual Roth Conference
Tribe Public’s Webinar Presentation and Q&A Event
March 6, 2025 - 8:30am PT / 11:30am ET
MPOX 2025: Navigating the Global Public Health Emergency
Emerging Growth Conference
| February 19, 2025 - 2:35 pm ET |
| Webcast |
BIO CEO & Investor Conference
| February 10, 2025 |
| New York, NY |
| Presentation |
Biotech Showcase
| January 14, 2025 - 10:30am PST |
| San Francisco, CA |
| Webcast |
Emerging Growth Conference
| January 16, 2025 - 2:35 pm ET |
| Webcast |
NobleCon20
Vaccines Summit
November 13-15, 2024
Boston, MA
3rd Annual ROTH Healthcare Opportunities Conference
Emerging Growth Conference
| September 25, 2024 at 2:55 pm ET |
| Webcast |
H.C. Wainwright 26th Annual Global Investment Conference
| September 9, 2024 - 7:00 am ET |
| New York, NY |
| H.C. Wainwright Webcast |
Tribe Public’s Webinar Presentation and Q&A Event
Emerging Growth Conference
August 21, 2024 - 4:10 pm ET
Q2 2024 GeoVax Labs, Inc. Business Update
August 6, 2024 - 4:30 PM ET
Emerging Growth Conference
International Pandemic Sciences Conference 2024
July 1-2, 2024
Oxford, United Kingdom
BIO International Convention
ASCO Annual Meeting
May 31-June 4, 2024
Chicago, IL
Q1 2024 GeoVax Labs, Inc. Business Update
May 14, 2024 - 4:30 PM ET
World Vaccine Congress Washington 2024
April 1-4, 2024
Speaker: Mark Newman, PhD, Chief Scientific Officer
Session Title: Vaccine Induction of Broadly-Specific Antibody and T Cell Responses to Combat SARS-CoV-2 Variation